Carl E. Clarke C
School of Clinical and Experimental Medicine
College of Medical and Dental Sciences
Birmingham
UK
Name/email consistency: high
- Comparison of speech and language therapy techniques for speech problems in Parkinson's disease. Herd, C.P., Tomlinson, C.L., Deane, K.H., Brady, M.C., Smith, C.H., Sackley, C.M., Clarke, C.E. Cochrane. Database. Syst. Rev (2012)
- Speech and language therapy versus placebo or no intervention for speech problems in Parkinson's disease. Herd, C.P., Tomlinson, C.L., Deane, K.H., Brady, M.C., Smith, C.H., Sackley, C.M., Clarke, C.E. Cochrane. Database. Syst. Rev (2012)
- Should treatment for Parkinson's disease start immediately on diagnosis or delayed until functional disability develops? Clarke, C.E., Patel, S., Ives, N., Rick, C., Wheatley, K., Gray, R. Mov. Disord. (2011)
- Has drug therapy changed the natural history of Parkinson's disease? Clarke, C.E. J. Neurol. (2010)
- Systematic review of apomorphine infusion, levodopa infusion and deep brain stimulation in advanced Parkinson's disease. Clarke, C.E., Worth, P., Grosset, D., Stewart, D. Parkinsonism Relat. Disord. (2009)
- Pilot randomised controlled trial of occupational therapy to optimise independence in Parkinson's disease: the PD OT trial. Clarke, C.E., Furmston, A., Morgan, E., Patel, S., Sackley, C., Walker, M., Bryan, S., Wheatley, K. J. Neurol. Neurosurg. Psychiatr. (2009)
- Are delayed-start design trials to show neuroprotection in Parkinson's disease fundamentally flawed?. Clarke, C.E. Mov. Disord. (2008)
- Rasagiline for motor complications in Parkinson's disease. Clarke, C.E. Lancet (2005)
- Ability of a nurse specialist to diagnose simple headache disorders compared with consultant neurologists. Clarke, C.E., Edwards, J., Nicholl, D.J., Sivaguru, A., Davies, P., Wiskin, C. J. Neurol. Neurosurg. Psychiatr. (2005)
- A "cure" for Parkinson's disease: can neuroprotection be proven with current trial designs?. Clarke, C.E. Mov. Disord. (2004)
- Tremor and deep white matter changes in alpha-methylacyl-CoA racemase deficiency. Clarke, C.E., Alger, S., Preece, M.A., Burdon, M.A., Chavda, S., Denis, S., Ferdinandusse, S., Wanders, R.J. Neurology (2004)
- Neuroprotection and pharmacotherapy for motor symptoms in Parkinson's disease. Clarke, C.E. Lancet. Neurol (2004)
- Beta-blocker therapy for tremor in Parkinson's disease. Crosby, N.J., Deane, K.H., Clarke, C.E. Cochrane. Database. Syst. Rev (2003)
- Amantadine in Parkinson's disease. Crosby, N., Deane, K.H., Clarke, C.E. Cochrane. Database. Syst. Rev (2003)
- Amantadine for dyskinesia in Parkinson's disease. Crosby, N.J., Deane, K.H., Clarke, C.E. Cochrane. Database. Syst. Rev (2003)
- Medical management of Parkinson's disease. Clarke, C.E. J. Neurol. Neurosurg. Psychiatr. (2002)
- Dopamine agonist monotherapy in Parkinson's disease. Clarke, C.E., Guttman, M. Lancet (2002)
- Speech and language therapy for dysarthria in Parkinson's disease. Deane, K.H., Whurr, R., Playford, E.D., Ben-Shlomo, Y., Clarke, C.E. Cochrane. Database. Syst. Rev (2001)
- A comparison of speech and language therapy techniques for dysarthria in Parkinson's disease. Deane, K.H., Whurr, R., Playford, E.D., Ben-Shlomo, Y., Clarke, C.E. Cochrane. Database. Syst. Rev (2001)
- Occupational therapy for patients with Parkinson's disease. Deane, K.H., Ellis-Hill, C., Playford, E.D., Ben-Shlomo, Y., Clarke, C.E. Cochrane. Database. Syst. Rev (2001)
- Physiotherapy for patients with Parkinson's Disease: a comparison of techniques. Deane, K.H., Jones, D., Playford, E.D., Ben-Shlomo, Y., Clarke, C.E. Cochrane. Database. Syst. Rev (2001)
- Systematic review of proton magnetic resonance spectroscopy of the striatum in parkinsonian syndromes. Clarke, C.E., Lowry, M. Eur. J. Neurol. (2001)
- Pergolide for levodopa-induced complications in Parkinson's disease. Clarke C, E., Speller J, M. Cochrane. Database. Syst. Rev (2000)
- Pergolide versus bromocriptine for levodopa-induced motor complications in Parkinson's disease. Clarke C, E., Speller J, M. Cochrane. Database. Syst. Rev (2000)
- Lisuride versus bromocriptine for levodopa-induced complications in Parkinson's disease. Clarke, C.E., Speller, J.M. Cochrane. Database. Syst. Rev (2000)
- Lisuride for levodopa-induced complications in Parkinson's disease. Clarke, C.E., Speller, J.M. Cochrane. Database. Syst. Rev (2000)
- Pramipexole versus bromocriptine for levodopa-induced complications in Parkinson's disease. Clarke C, E., Speller J, M., Clarke J, A. Cochrane. Database. Syst. Rev (2000)
- Pramipexole for levodopa-induced complications in Parkinson's disease. Clarke C, E., Speller J, M., Clarke J, A. Cochrane. Database. Syst. Rev (2000)
- Systematic review of acute levodopa and apomorphine challenge tests in the diagnosis of idiopathic Parkinson's disease. Clarke, C.E., Davies, P. J. Neurol. Neurosurg. Psychiatr. (2000)